109 related articles for article (PubMed ID: 37666442)
1. Inhibition of AKR1Cs by liquiritigenin and the structural basis.
Liu H; Yao Z; Sun M; Zhang C; Huang YY; Luo HB; Wu D; Zheng X
Chem Biol Interact; 2023 Nov; 385():110654. PubMed ID: 37666442
[TBL] [Abstract][Full Text] [Related]
2. In vitro inhibition of AKR1Cs by sulphonylureas and the structural basis.
Zhao Y; Zheng X; Zhang H; Zhai J; Zhang L; Li C; Zeng K; Chen Y; Li Q; Hu X
Chem Biol Interact; 2015 Oct; 240():310-5. PubMed ID: 26362498
[TBL] [Abstract][Full Text] [Related]
3. The estrogen receptor beta agonist liquiritigenin enhances the inhibitory effects of the cholesterol biosynthesis inhibitor RO 48-8071 on hormone-dependent breast-cancer growth.
Liang Y; Besch-Williford C; Hyder SM
Breast Cancer Res Treat; 2022 Feb; 192(1):53-63. PubMed ID: 35037188
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3): overview and structural insights.
Byrns MC; Jin Y; Penning TM
J Steroid Biochem Mol Biol; 2011 May; 125(1-2):95-104. PubMed ID: 21087665
[TBL] [Abstract][Full Text] [Related]
5. Tibolone is metabolized by the 3alpha/3beta-hydroxysteroid dehydrogenase activities of the four human isozymes of the aldo-keto reductase 1C subfamily: inversion of stereospecificity with a delta5(10)-3-ketosteroid.
Steckelbroeck S; Jin Y; Oyesanmi B; Kloosterboer HJ; Penning TM
Mol Pharmacol; 2004 Dec; 66(6):1702-11. PubMed ID: 15383625
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hepatoma 22 tumor by Liquiritigenin.
Zhou M; Higo H; Cai Y
Phytother Res; 2010 Jun; 24(6):827-33. PubMed ID: 19953525
[TBL] [Abstract][Full Text] [Related]
7. An indomethacin analogue, N-(4-chlorobenzoyl)-melatonin, is a selective inhibitor of aldo-keto reductase 1C3 (type 2 3alpha-HSD, type 5 17beta-HSD, and prostaglandin F synthase), a potential target for the treatment of hormone dependent and hormone independent malignancies.
Byrns MC; Steckelbroeck S; Penning TM
Biochem Pharmacol; 2008 Jan; 75(2):484-93. PubMed ID: 17950253
[TBL] [Abstract][Full Text] [Related]
8. Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling.
Ji Q; Aoyama C; Nien YD; Liu PI; Chen PK; Chang L; Stanczyk FZ; Stolz A
Cancer Res; 2004 Oct; 64(20):7610-7. PubMed ID: 15492289
[TBL] [Abstract][Full Text] [Related]
9. Hydroxytriazole derivatives as potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors discovered by bioisosteric scaffold hopping approach.
Pippione AC; Giraudo A; Bonanni D; Carnovale IM; Marini E; Cena C; Costale A; Zonari D; Pors K; Sadiq M; Boschi D; Oliaro-Bosso S; Lolli ML
Eur J Med Chem; 2017 Oct; 139():936-946. PubMed ID: 28881288
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: the role of IL-6 signaling and Nrf2/AKR1C axis identification.
Chen CC; Chu CB; Liu KJ; Huang CY; Chang JY; Pan WY; Chen HH; Cheng YH; Lee KD; Chen MF; Kuo CC; Chen LT
Biochem Pharmacol; 2013 Oct; 86(7):872-87. PubMed ID: 23933386
[TBL] [Abstract][Full Text] [Related]
11. Liquiritigenin suppresses the activation of hepatic stellate cells via targeting miR-181b/PTEN axis.
Geng W; Zhou G; Zhao B; Xiao Q; Li C; Fan S; Dong P; Zheng J
Phytomedicine; 2020 Jan; 66():153108. PubMed ID: 31790896
[TBL] [Abstract][Full Text] [Related]
12. Aldo-keto reductase 1C subfamily genes in skin are UV-inducible: possible role in keratinocytes survival.
Marín YE; Seiberg M; Lin CB
Exp Dermatol; 2009 Jul; 18(7):611-8. PubMed ID: 19320734
[TBL] [Abstract][Full Text] [Related]
13. Liquiritigenin decreases selective molecular and behavioral effects of cocaine in rodents.
Jang EY; Hwang M; Yoon SS; Lee JR; Kim KJ; Kim HC; Yang CH
Curr Neuropharmacol; 2011 Mar; 9(1):30-4. PubMed ID: 21886557
[TBL] [Abstract][Full Text] [Related]
14. Type 5 17beta-hydroxysteroid dehydrogenase/prostaglandin F synthase (AKR1C3): role in breast cancer and inhibition by non-steroidal anti-inflammatory drug analogs.
Byrns MC; Penning TM
Chem Biol Interact; 2009 Mar; 178(1-3):221-7. PubMed ID: 19010312
[TBL] [Abstract][Full Text] [Related]
15. Liquiritigenin, a flavonoid aglycone from licorice, has a choleretic effect and the ability to induce hepatic transporters and phase-II enzymes.
Kim YW; Kang HE; Lee MG; Hwang SJ; Kim SC; Lee CH; Kim SG
Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G372-81. PubMed ID: 19074639
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of liquiritigenin on migration via downregulation proMMP-2 and PI3K/Akt signaling pathway in human lung adenocarcinoma A549 cells.
Wang Y; Xie S; Liu C; Wu Y; Liu Y; Cai Y
Nutr Cancer; 2012; 64(4):627-34. PubMed ID: 22519916
[TBL] [Abstract][Full Text] [Related]
17. Liquiritigenin exerts the anti-cancer role in oral cancer via inducing autophagy-related apoptosis through PI3K/AKT/mTOR pathway inhibition
Ji Y; Hu W; Jin Y; Yu H; Fang J
Bioengineered; 2021 Dec; 12(1):6070-6082. PubMed ID: 34488535
[TBL] [Abstract][Full Text] [Related]
18. Liquiritigenin exhibits antitumour action in pituitary adenoma cells via Ras/ERKs and ROS-dependent mitochondrial signalling pathways.
Wang D; Wong HK; Feng YB; Zhang ZJ
J Pharm Pharmacol; 2014 Mar; 66(3):408-17. PubMed ID: 24491032
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of human type-5 17β-hydroxysteroid dehydrogenase (AKR1C3) by baccharin, a component of Brazilian propolis.
Endo S; Matsunaga T; Kanamori A; Otsuji Y; Nagai H; Sundaram K; El-Kabbani O; Toyooka N; Ohta S; Hara A
J Nat Prod; 2012 Apr; 75(4):716-21. PubMed ID: 22506594
[TBL] [Abstract][Full Text] [Related]
20. Liquiritigenin-Loaded Submicron Emulsion Protects Against Doxorubicin-Induced Cardiotoxicity via Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Activity.
Shi C; Wu H; Xu K; Cai T; Qin K; Wu L; Cai B
Int J Nanomedicine; 2020; 15():1101-1115. PubMed ID: 32110010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
